FAST NEWS: WuXi Biologics Announces $300 Million Share Buyback
The latest: Contract drugs services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Monday its board of directors has approved a plan to buy back up to $300 million of the…
Recent Articles
RELATED ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK -
East Buy ends superstar influencer addiction – but at a big price
1797.HK
-
BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
2359.HK 603259.SHG
-
NEWS WRAP: J&T Express sets ‘Double 11’ shipment milestone as share buyback launches
1519.HK
